 BACKGROUND: Colorectal cancer (CRC) disease major impact public health public health costs. Colonoscopy purportedly best screening tool CRC. However, acceptance general population poor. Therefore evaluation additional screening tools great interest. PATIENTS METHODS: use M2-PK measurement feces reported 6 studies date. data studies analysed critically reviewed. Additionally, 1,906 persons undergoing routine health care check-up provided stool samples M2-PK measurement. RESULTS: overall sensitivity M2-PK 77.9% CRC. Specificity ranges 74.3 83.3%. 1,906 screened persons, 90.4% results within normal range, 9.6% elevated results. CONCLUSION: Measurement tumor M2-PK feces seems promising tool CRC screening present time. combination colonoscopy, test hence recommended CRC screening programs.